Sodium Picosulfate + Magnesium Oxide + Citric Acid interactions
Checked as Magnesium oxide + Citric acid in this data source.
Full monograph for Sodium Picosulfate + Magnesium Oxide + Citric AcidCheck it against another medicine
Medicines
234 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Aluminium Hydroxide + Magnesium Hydroxidevia Citric acid, Magnesium oxide | Major | Absorption · Synergy | The concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum…3 documented mechanisms | 11 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide + Simethiconevia Citric acid, Magnesium oxide | Major | Absorption · Synergy | The concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum…3 documented mechanisms | 11 sources — open the full entry |
| Erdafitinibvia Magnesium oxide | Major | Others | Coadministration with agents that can alter serum phosphate levels may affect the initial dosage determination of erdafitinib. The mechanism appears to be… | 1 sources — open the full entry |
| Gefitinibvia Magnesium oxide | Major | Absorption | Coadministration with drugs that elevate gastric pH such as H2-receptor antagonists and antacids may decrease the plasma concentrations of gefitinib. According… | 5 sources — open the full entry |
| Selpercatinibvia Magnesium oxide | Major | Absorption | Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of selpercatinib and reduce its concentrations in… | 2 sources — open the full entry |
| Sotorasibvia Magnesium oxide | Major | Absorption | Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of sotorasib and reduce its concentrations in plasma. | 2 sources — open the full entry |
| Acalabrutinibvia Magnesium oxide | Moderate | Absorption | INTERVAL: Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of acalabrutinib and reduce its… | 2 sources — open the full entry |
| Alendronic acidvia Magnesium oxide | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Alendronic Acid + Vitamin D3via Magnesium oxide | Moderate | Absorption · Synergy | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to…2 documented mechanisms | 13 sources — open the full entry |
| Algae Calcium + Vitamin D3via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Aluminium Oxide + Magnesium Trisilicatevia Magnesium oxide | Moderate | Synergy | The concomitant administration of magnesium salts with other magnesium-containing preparations such as antacids or laxatives may increase the risk of magnesium… | 1 sources — open the full entry |
| Aspirinvia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Aspirin + Dipyridamolevia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Baloxavir Marboxilvia Magnesium oxide | Moderate | Absorption | Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed… | 3 sources — open the full entry |
| Benzoic Acid + Salicylic Acidvia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Betamethasone Dipropionate + Salicylic Acidvia Magnesium oxide | Moderate | Absorption · Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism…2 documented mechanisms | 11 sources — open the full entry |
| Calcitriolvia Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium + Vitamin D3 + Multimineralvia Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium acetate + Magnesium carbonatevia Magnesium oxide | Moderate | Synergy | The concomitant administration of magnesium salts with other magnesium-containing preparations such as antacids or laxatives may increase the risk of magnesium… | 1 sources — open the full entry |
| Calcium Citrate + Calcitriolvia Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C + Vitamin D3via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 + Multimineralsvia Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Phosphate [Milk source] + Vitamin D3via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Carbonyl Iron + Folic Acidvia Magnesium oxide | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carbonyl Iron + Folic Acid + Zinc Sulfatevia Magnesium oxide | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carbonyl Iron + Folic Acid + Zinc Sulfate + Vitamin B Complex + Vitamin Cvia Magnesium oxide | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Cefdinirvia Magnesium oxide | Moderate | Absorption | INTERVAL: Aluminum- or magnesium-containing antacids may interfere with the rate and extent of absorption of cefdinir. The mechanism has not been described but… | 1 sources — open the full entry |
| Cefditorenvia Magnesium oxide | Moderate | Absorption | Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral absorption and plasma concentrations of cefditoren pivoxil. | 2 sources — open the full entry |
| Cefpodoxime Proxetilvia Magnesium oxide | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Cefpodoxime Proxetil + Clavulanic Acidvia Magnesium oxide | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Cefuroxime Axetilvia Magnesium oxide | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Cefuroxime Axetil + Clavulanic Acidvia Magnesium oxide | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Ceritinibvia Magnesium oxide | Moderate | Absorption | Drugs that alter the pH of the upper gastrointestinal tract may affect the solubility of ceritinib and reduce its bioavailability. The interaction has not been… | 2 sources — open the full entry |
| Cetalkonium Chloride + Choline Salicylatevia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Chloroquine Phosphatevia Magnesium oxide | Moderate | Absorption | INTERVAL: Concomitant administration of antacids or kaolin may reduce the oral bioavailability of chloroquine. The proposed mechanism is adsorption of… | 9 sources — open the full entry |
| Cholecalciferol [Vitamin D3]via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| CiprofloxacinbaseOphthalmicvia Magnesium oxide, Citric acid | Moderate | Absorption · Excretion | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…3 documented mechanisms | 36 sources — open the full entry |
| Ciprofloxacin + Dexamethasonevia Magnesium oxide, Citric acid | Moderate | Absorption · Excretion | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…4 documented mechanisms | 39 sources — open the full entry |
| Ciprofloxacin + Hydrocortisone Acetatevia Magnesium oxide, Citric acid | Moderate | Absorption · Excretion | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…3 documented mechanisms | 36 sources — open the full entry |
| Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafinevia Magnesium oxide, Citric acid | Moderate | Absorption · Excretion | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…3 documented mechanisms | 36 sources — open the full entry |
| Clobetasol Propionate + Salicylic Acidvia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Clopidogrel + Aspirinvia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Coal Tar + Precipitated Sulphur + Salicylic Acidvia Magnesium oxide | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Conventional Calcium + Vitamin D3via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Coral Calcium + Vitamin D3via Magnesium oxide | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Dabigatran Etexilate Mesylatevia Magnesium oxide | Moderate | Absorption | Coadministration with an antacid may reduce the bioavailability of dabigatran following oral administration of dabigatran etexilate. | 1 sources — open the full entry |
| Dasatinibvia Magnesium oxide | Moderate | Absorption | INTERVAL: Nonclinical data indicate that the solubility of dasatinib is pH-dependent. Therefore, coadministration with antacids or agents with… | 4 sources — open the full entry |
| Deferipronevia Magnesium oxide | Moderate | Absorption | INTERVAL: Deferiprone has the potential to bind polyvalent cations such as aluminum, iron and zinc, which may reduce its effectiveness. However, concurrent use… | 1 sources — open the full entry |
| Delafloxacinvia Magnesium oxide | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
Conditions
Conditions in which Sodium Picosulfate + Magnesium Oxide + Citric Acid needs care, as documented in this source.
Kidney Diseases
MajorMagnesium is eliminated by the kidney. The serum concentration of magnesium is increased in patients with renal impairment. Magnesium toxicity includes CNS depression, muscular paralysis, respiratory depression, hypotension and prolonged cardiac conduction time. Disappearance of the patellar reflex is a useful clinical sign of magnesium intoxication. Therapy with magnesium should be administered cautiously and dosages should be modified in patients with compromised renal function. Clinical monitoring of serum magnesium levels is recommended.
5 sources
- "Product Information. Mag-Ox 400 (magnesium oxide)." Blaine Company Inc. (2001):
- "Product Information. Uro-Mag (magnesium oxide)." Blaine Company Inc. (2001):
- "Product Information. Slow-Mag (magnesium chloride)." Searle (2001):
- "Product Information. Magonate (magnesium gluconate)." Fleming and Company (2001):
- "Product Information. Losospan (magaldrate)." Whitehall-Robbins (2001):
Therapeutic duplication
Drug classes that overlap with Sodium Picosulfate + Magnesium Oxide + Citric Acid, so taking both doubles up the same effect. This source publishes no per-row citations for duplication.
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Nu-mag
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Renacidin
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Suprep bowel prep kit
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Sutab
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Aluminum hydroxide/magnesium carbonate